Profilo
Debra Segal is currently the Head of Regulatory Affairs at Dianthus Therapeutics, Inc. Prior to her current position, she served as the Senior Vice President of Regulatory Affairs at Scholar Rock, Inc. from 2021 to 2023.
Posizioni attive di Debra Segal
| Società | Posizione | Inizio |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Consigliere Generale | 11/09/2023 |
Precedenti posizioni note di Debra Segal
| Società | Posizione | Fine |
|---|---|---|
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Consigliere Generale | 01/03/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Debra Segal
